The effect of cyst(e)ine on the auto-oxidation of homocysteine

Free Radical Biology and Medicine

Volumn 27, Issue 1-2, 1999, Pages 28-33

  Hogg, Neil ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Autoxidation; Cysteine; Free radicals; Homocysteine; Oxidative stress

Indexed keywords

CYSTEINE; FREE RADICAL; HOMOCYSTEINE; OXYGEN DERIVATIVE;

ARTERIOSCLEROSIS; ARTICLE; AUTOOXIDATION; HYPERHOMOCYSTEINEMIA; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR DISEASE;

CYSTEINE; CYSTINE; GLUTATHIONE; HOMOCYSTEINE; OXIDATION-REDUCTION;

EID: 0032797368     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(99)00029-5     Document Type: Article

References (14)

1. Boushey C.J., Beresford S.A.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 274:1995;1049-1057.
2. Graham I.M., Daly L.E., Refsum H.M., Robinson K., Brattstrom L.E., Ueland P.M., Palma-Reis R.J., Boers G.H.J., Sheahan R.G., Israelsson B., Uiterwaal C.S., Meleady R., McMaster D., Verhoef P., Witteman J., Rubba P., Bellet H., Wautrecht J.C., de Valk H.W., Sales Luis A.C., Parrot-Roulaud F.M., Tan K.S., Higgins I., Garcon D., Medrano M.J., Candito M., Evans A.E., Generoso A. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA. 277:1998;1775-1781.
3. Ueland P.M., Refsum H.M. Plasma homocysteine, a risk factor for vascular disease Plasma levels in health, disease, and drug therapy . J. Lab. Clin. Chem. 114:1989;473-501.
4. McCully K.S., Wilson R.B. Homocysteine theory of arteriosclerosis. Atherosclerosis. 22:1975;215-227.
5. Welch G.N., Upchurch G.R., Loscalzo J. Homocysteine, oxidative stress, and vascular disease. Hosp. Pract. 32:1997;81-92.
6. Starkebaum G., Harlan J.M. Endothelial cell injury due to copper-catalyzed endothelia cell injury from homocysteine. J. Clin. Invest. 77:1986;1370-1376.
7. Harrison D.G. Cellular and molecular mechanisms of endothelial dysfunction. J. Clin. Invest. 100:1997;2153-2157.
8. Mansoor M.A., Bergmark C., Svardal A.M., Ueland P.M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 15:1995;232-240.
9. Ueland P.M., Mansoor M.A., Guttorsmen A.B., Refsum H.M., Aukrust P., Svardal A.M. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status - a possible element of the extracellular antioxidant defense system. J. Nutr. 126:1996;1281S-1284S.
10. Durand P., Fortin L.J., Lussier-Cacan S., Davignon J., Blache D. Hyperhomocystinemia induced by folic acid deficiency and methionine load - applications of a modified HPLC method. Clinica Chimica Acta. 252:1996;83-93.
11. Hanaki A., Kamaide H. Autoxidation of cysteine catalyzed by copper in glycylglycine buffer. Chem. Pharm. Bull. 23:1975;1671-1676.
12. Winterbourn C.C. Superoxide as an intracellular radical sink. Free Radic. Biol. Med. 14:1993;85-90.
13. Nath K.A., Salahudeen A.K. Autoxidation of cysteine generates hydrogen peroxide cytotoxicity and attenuation by pyruvate . Am. J. Physiol. 264:1993;F306-F314.
14. Vina J., Saez G.T., Wiggins D., Roberts A.F., Hems R., Krebs H.A. The effects of cysteine oxidation on isolated hepatocytes. Biochem. J. 313:1983;39-44.